Abstract
206P An innovative evidence-based laboratory medicine (EBLM) test to help doctors in the screening of hepatocellular carcinoma (HCC)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
https://doi.org/10.1016/j.annonc.2024.05.214
Publication Date: Jun 1, 2024 |
206P An innovative evidence-based laboratory medicine (EBLM) test to help doctors in the screening of hepatocellular carcinoma (HCC)
Join us for a 30 min session where you can share your feedback and ask us any queries you have